Cryopreservation Equipment Market, by Equipment (Freezers (Cryopreservation Freezers, Drystore Freezers), Incubators, Sample Preparation System, and Accessories), by Cryogen (Liquid Nitrogen, Oxygen, Argon, and Liquid helium), by Application (Cord Blood S

Cryopreservation Equipment Market, by Equipment (Freezers (Cryopreservation Freezers, Drystore Freezers), Incubators, Sample Preparation System, and Accessories), by Cryogen (Liquid Nitrogen, Oxygen, Argon, and Liquid helium), by Application (Cord Blood Stem Cells, Sperms, Semen & Testicular Tissues, Embryos & Oocytes, Other Application), by End User (Stem Cells Banks, Biotechnology and Pharmaceutical organizations, Contract Research Organizations, Stem Cell Research Laboratories, and Research and Academic Institutes), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)- Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030

Cryopreservation is a process of maintaining biological samples in a form of suspended state at cryogenic temperature for considerable period of time and is used to preserve the fine structure of cells. Through this process, samples of cells, tissues, and organelles are cooled at very low temperatures (less than -2130F), for preservation. Cryopreservation is primarily used in the preservation of oocytes and embryos with in-vitro fertilization (IVF) cycle, prior to chemotherapy for women diagnosed with breast cancer, in order to preserve their reproductive capacity. The purpose of cryopreservation is to store cells indefinitely by halting the cell's metabolism with ultralow temperatures. The freeze-thaw process is stressful to all cells and tissues. Therefore, effective techniques were developed to prevent cell death and damage. Individuals or couples may choose cryopreservation to preserve fertility during cancer treatments or delay a pregnancy attempt until sometime in the future. The objective of cryopreservation is to minimize damage to biological materials, including tissues, mammalian cells, bacteria, fungi, plant cells, and viruses, during low temperature freezing and storage. When performed correctly and accounting for cell and tissue specific criteria, cryopreservation can provide a continuous source of tissues and genetically stable living cells for a variety of purposes, including research and biomedical processes.

Market Dynamics

Increase in new technology launches for efficient working of cryopreservative equipment by key players is expected to drive the global cryopreservation equipment market over the forecast period. For instance, in September 2019, ASKION C-line, of automated bio banking in the temperature range down to -185°C, launched its new technology ASKION C-line work bench (WB) consisting of a cryogenic handlings area (T <-100°C), which can be equipped with two (WB220), three (WB230) or six (aWB) controlled rate freezers. Inside the cryogenic handlings area a dry nitrogen atmosphere with ultra-low temperature is generated. This cryogenic environment enables to sort and/or temporarily store your frozen, by maintain the best sample quality of samples. The internal /external barcode scanners allow identification and tracking of samples at any time (barcode-based sample management). The optional controlled rate freezers guarantee to freeze down different sample formats in a defined and reproducible manner while recording all relevant data. The controlled rate freezing can be carried out by using freely programmable freezing curves.

Key features of the study:

• This report provides an in-depth analysis of the global cryopreservation equipment market, and provides market size (US$ Million) and compound annual growth rate (CAGR%) for the forecast period (2022–2030), considering 2021 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global cryopreservation equipment market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include Thermo Fisher Scientific, Inc., Custom Biogenic Systems, Chart Biomedical Co. Ltd., Merck KGaA, Barber-Nichols Inc., Praxair Technology, Inc., Linde LLC, Planer PLC, Cryologic Pty. Ltd., Charter Medicals, Nikkiso Cryo Inc., Cryogenic Control, and Haimen United Laboratory Equipment Development Co., Ltd.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The global cryopreservation equipment market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global cryopreservation equipment market

Detailed Segmentation:

• Global Cryopreservation Equipment Market, By Equipment:
• Freezers
• Cryopreservation Freezers
• Drystore Freezers
• Incubators
• Sample Preparation Systems
• Accessories
• Cryopreservation Vials
• Freezer Box
• Cryocart
• Cryogenic Vaporizer
• Other Accessories
• Global Cryopreservation Equipment Market, By Cryogen:
• Liquid Nitrogen
• Oxygen
• Argon
• Liquid Helium
• Global Cryopreservation Equipment Market, By Application:
• Cord Blood Stem Cells
• Sperms, Semen & Testicular Tissues
• Embryos & Oocytes
• Other Application
• Global Cryopreservation Equipment Market, By End User:
• Stem Cells Banks
• Biotechnology and Pharmaceutical organizations
• Contract Research Organizations
• Stem Cell Research Laboratories
• Research and Academic Institutes
• Global Cryopreservation Equipment Market, By Region:
• North America
• By Country
• U.S.
• Canada
• Latin America
• By Country
• Brazil
• Mexico
• Argentina
• Rest of Latin America
• Europe
• By Country
• Germany
• U.K.
• France
• Italy
• Spain
• Russia
• Rest of Europe
• Asia Pacific
• By Country
• China
• India
• Japan
• Australia
• South Korea
• ASEAN
• Rest of Asia Pacific
• Middle East
• By Country
• GCC
• Israel
• Rest of Middle East
• Africa
• By Region/Country
• South Africa
• Central Africa
• North Africa
• Company Profiles
• Thermo Fisher Scientific, Inc.
• Company Highlights
• Products Portfolio
• Key Highlights
• Financial Performance
• Strategies
• Recent Developments
• Future Plans
• Custom Biogenic Systems
• Chart Biomedical Co. Ltd.
• Merck KGaA
• Barber-Nichols Inc.
• Praxair Technology, Inc.
• Linde LLC
• Planer PLC
• Cryologic Pty. Ltd.
• Charter Medicals
• Nikkiso Cryo Inc.
• Cryogenic Control
• Haimen United Laboratory Equipment Development Co., Ltd.

“*” marked represents similar segmentation in other categories in the respective section.